Mammary stem cells and their regulation by steroid hormones

Marie-Liesse Labat, Geoffrey J. Lindeman, Jane E. Visvader

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Sustained exposure to estrogen and progesterone is a well-established risk factor for breast cancer. These hormones play a central role in the female reproductive cycle, in which they control morphogenesis of the mammary gland during puberty, ovulatory cycles and pregnancy. Mouse mammary stem cells (MaSCs) have recently been discovered to be highly responsive to female hormones, despite lacking expression of the estrogen and progesterone receptors. The inhibition of MaSCs by hormone receptor antagonists further suggests that these cells contribute to oncogenesis. Identification of paracrine mediators of hormone signaling to MaSCs may lead to the development of novel inhibitors that drive MaSCs into a more quiescent state. In this context, inhibition of the receptor activator of NF-B/receptor activator of NF-B ligand signaling pathway has profound implications for the prevention of breast cancer.

Original languageEnglish (US)
Pages (from-to)371-381
Number of pages11
JournalExpert Review of Endocrinology and Metabolism
Volume6
Issue number3
DOIs
StatePublished - May 1 2011
Externally publishedYes

Fingerprint

Breast
Stem Cells
Steroids
Hormones
Breast Neoplasms
Hormone Antagonists
Progesterone Receptors
Human Mammary Glands
Puberty
Morphogenesis
Estrogen Receptors
Progesterone
Estrogens
Carcinogenesis
Ligands
Pregnancy

Keywords

  • breast cancer
  • denosumab
  • estrogen
  • mammary stem cell
  • progesterone
  • RANK
  • RANKL
  • steroid hormones

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Mammary stem cells and their regulation by steroid hormones. / Labat, Marie-Liesse; Lindeman, Geoffrey J.; Visvader, Jane E.

In: Expert Review of Endocrinology and Metabolism, Vol. 6, No. 3, 01.05.2011, p. 371-381.

Research output: Contribution to journalReview article

Labat, Marie-Liesse ; Lindeman, Geoffrey J. ; Visvader, Jane E. / Mammary stem cells and their regulation by steroid hormones. In: Expert Review of Endocrinology and Metabolism. 2011 ; Vol. 6, No. 3. pp. 371-381.
@article{5e07fd53a1ee42a488abb6bc30fd43a1,
title = "Mammary stem cells and their regulation by steroid hormones",
abstract = "Sustained exposure to estrogen and progesterone is a well-established risk factor for breast cancer. These hormones play a central role in the female reproductive cycle, in which they control morphogenesis of the mammary gland during puberty, ovulatory cycles and pregnancy. Mouse mammary stem cells (MaSCs) have recently been discovered to be highly responsive to female hormones, despite lacking expression of the estrogen and progesterone receptors. The inhibition of MaSCs by hormone receptor antagonists further suggests that these cells contribute to oncogenesis. Identification of paracrine mediators of hormone signaling to MaSCs may lead to the development of novel inhibitors that drive MaSCs into a more quiescent state. In this context, inhibition of the receptor activator of NF-B/receptor activator of NF-B ligand signaling pathway has profound implications for the prevention of breast cancer.",
keywords = "breast cancer, denosumab, estrogen, mammary stem cell, progesterone, RANK, RANKL, steroid hormones",
author = "Marie-Liesse Labat and Lindeman, {Geoffrey J.} and Visvader, {Jane E.}",
year = "2011",
month = "5",
day = "1",
doi = "10.1586/eem.11.22",
language = "English (US)",
volume = "6",
pages = "371--381",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Mammary stem cells and their regulation by steroid hormones

AU - Labat, Marie-Liesse

AU - Lindeman, Geoffrey J.

AU - Visvader, Jane E.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Sustained exposure to estrogen and progesterone is a well-established risk factor for breast cancer. These hormones play a central role in the female reproductive cycle, in which they control morphogenesis of the mammary gland during puberty, ovulatory cycles and pregnancy. Mouse mammary stem cells (MaSCs) have recently been discovered to be highly responsive to female hormones, despite lacking expression of the estrogen and progesterone receptors. The inhibition of MaSCs by hormone receptor antagonists further suggests that these cells contribute to oncogenesis. Identification of paracrine mediators of hormone signaling to MaSCs may lead to the development of novel inhibitors that drive MaSCs into a more quiescent state. In this context, inhibition of the receptor activator of NF-B/receptor activator of NF-B ligand signaling pathway has profound implications for the prevention of breast cancer.

AB - Sustained exposure to estrogen and progesterone is a well-established risk factor for breast cancer. These hormones play a central role in the female reproductive cycle, in which they control morphogenesis of the mammary gland during puberty, ovulatory cycles and pregnancy. Mouse mammary stem cells (MaSCs) have recently been discovered to be highly responsive to female hormones, despite lacking expression of the estrogen and progesterone receptors. The inhibition of MaSCs by hormone receptor antagonists further suggests that these cells contribute to oncogenesis. Identification of paracrine mediators of hormone signaling to MaSCs may lead to the development of novel inhibitors that drive MaSCs into a more quiescent state. In this context, inhibition of the receptor activator of NF-B/receptor activator of NF-B ligand signaling pathway has profound implications for the prevention of breast cancer.

KW - breast cancer

KW - denosumab

KW - estrogen

KW - mammary stem cell

KW - progesterone

KW - RANK

KW - RANKL

KW - steroid hormones

UR - http://www.scopus.com/inward/record.url?scp=79956090558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956090558&partnerID=8YFLogxK

U2 - 10.1586/eem.11.22

DO - 10.1586/eem.11.22

M3 - Review article

AN - SCOPUS:79956090558

VL - 6

SP - 371

EP - 381

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 3

ER -